Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1468 studies found for:    Parkinson's Disease
Show Display Options
Rank Status Study
21 Completed
Has Results
Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life
Condition: Parkinson Disease
Intervention:
22 Completed
Has Results
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
Condition: Parkinson's Disease
Interventions: Drug: Carbidopa/levodopa/entacapone;   Drug: Immediate release carbidopa/levodopa
23 Terminated Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: CEP-1347 10mg;   Drug: CEP1347 25mg;   Drug: CEP-1347 50mg;   Other: Placebo Comparator
24 Completed
Has Results
Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: Neupro®
25 Recruiting Study for the Early Diagnosis of Parkinson's Disease
Condition: Parkinson's Disease, Idiopathic
Intervention:
26 Terminated
Has Results
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Coenzyme Q10 with vitamin E;   Drug: placebo with vitamin E
27 Completed Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients
Condition: IDIOPATHIC PARKINSON'S DISEASE
Interventions: Drug: Rotigotine;   Drug: Placebo Patch
28 Completed
Has Results
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
Condition: Parkinson's Disease
Interventions: Drug: Levodopa/carbidopa/entacapone;   Drug: Levodopa/carbidopa
29 Completed A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
Condition: Parkinson's Disease With Cognitive Impairments
Interventions: Drug: safinamide;   Drug: placebo
30 Completed
Has Results
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Condition: Parkinson's Disease Dementia
Interventions: Drug: Rivastigmine capsule;   Drug: Rivastigmine transdermal patch
31 Completed The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: pramipexole;   Drug: Sinemet CR
32 Completed Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Conditions: Parkinson's Disease;   Depression
Intervention: Device: Repetitive transcranial magnetic stimulation (rTMS)
33 Completed Effectiveness Study of Occupational Therapy in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Behavioral: Occupational Therapy
34 Completed
Has Results
A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline Mesylate;   Other: Placebo
35 Recruiting Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Procedure: Harvesting and Implantation of Adipose-Derived Stem Cells
36 Recruiting Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Conditions: Cough;   Parkinson's Disease
Interventions: Drug: Capsaicin;   Other: Healthy Older Adults;   Other: Parkinson's Disease
37 Completed
Has Results
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Isradipine CR 5mg;   Drug: Isradipine CR 10mg;   Drug: Isradipine CR 20mg;   Drug: Placebo
38 Completed Pioglitazone in Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Pioglitazone;   Drug: placebo
39 Unknown  Sensory Attention Focused Exercise in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Other: Sensory Attention Focused Exercise (SAFEx)
40 Completed
Has Results
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
Condition: Parkinson's Disease
Intervention: Drug: SPM 962

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years